Free Trial

Prestige Consumer Healthcare Q3 2023 Earnings Report

Prestige Consumer Healthcare logo
$84.70 -0.30 (-0.35%)
(As of 12/3/2024 ET)

Prestige Consumer Healthcare EPS Results

Actual EPS
$1.04
Consensus EPS
$1.01
Beat/Miss
Beat by +$0.03
One Year Ago EPS
$0.99

Prestige Consumer Healthcare Revenue Results

Actual Revenue
$275.50 million
Expected Revenue
$273.84 million
Beat/Miss
Beat by +$1.66 million
YoY Revenue Growth
+0.40%

Prestige Consumer Healthcare Announcement Details

Quarter
Q3 2023
Time
Before Market Opens
Elon Musk’s chilling warning for humanity (Ad)

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.

Go here to see why.

Prestige Consumer Healthcare Earnings Headlines

What is Zacks Research's Estimate for PBH Q4 Earnings?
Lock in this disruptor’s share price before 12/5
Spencer Rascoff co-founded Zillow. Austin Allison sold his company to Zillow for $125M. Now they’ve joined forces to launch a venture transforming the $1.3T vacation home market – and the results are already turning heads. This company is leading the co-ownership revolution, offering buyers a chance to own a fraction of a luxury vacation home instead of the entire thing. It’s a model that’s unlocked new demand and earned them over $100M in gross profits in four years.
See More Prestige Consumer Healthcare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prestige Consumer Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prestige Consumer Healthcare and other key companies, straight to your email.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

View Prestige Consumer Healthcare Profile

More Earnings Resources from MarketBeat